Literature DB >> 35848175

[Clinical application of three-dimensional printed osteotomy guide plate and personalized prosthesis in knee-preserving tumor resection].

Weijian Liu1, Baichuan Wang1, Hongzhi Hu1, Feifei Pu1, Jianxiang Liu1, Qiang Wu1, Zhicai Zhang1, Yingze Zhang1, Zengwu Shao1.   

Abstract

Objective: To investigate the mid-term effectiveness of three-dimensional (3D) printed osteotomy guide plate and personalized prosthesis in knee-preserving tumor resection.
Methods: The clinical data of 12 patients who underwent knee-preserving tumor resection and reconstruction with 3D printed osteotomy guide plate and personalized prosthesis between September 2016 and October 2018 were retrospectively analyzed. There were 7 males and 5 females. The age ranged from 7 to 59 years, with a median of 44.5 years. There were 11 cases of osteosarcoma and 1 case of fibrosarcoma, all of which were Enneking grade ⅡB. The distance from the tumor to the joint surface was 5.5-8.2 cm, with an average of 6.94 cm. Incision healing, tumor recurrence, periprosthetic fracture, and aseptic loosening were observed after operation. The Musculoskeletal Tumor Society (MSTS) scoring system was used to evaluate the function of the patients, and the knee flexion range of motion was measured.
Results: The 12 patients were followed up 41-66 months, with an average of 54.5 months. The length of osteotomy ranged from 14 to 26 cm, with an average of 22.08 cm. Except for 2 patients with superficial infection of incision tissue, no deep infection involving the prosthesis occurred, no patient underwent revision surgery because of prosthesis infection. During the follow-up, local recurrence occurred in 2 cases and distant metastasis occurred in 3 cases. The overall disease-free survival rate was 58.3%. Two patients died of lung metastasis, and the overall survival rate was 83.3%. One patient underwent amputation due to local recurrence, and 1 patient underwent total knee arthroplasty due to prosthesis rupture. No aseptic loosening of the prosthesis and periprosthetic fracture occurred during the follow-up, and the overall prosthesis survival rate was 83.3%. At last follow-up, 10 patients obtained satisfactory knee flexion range of motion that ranged from 95° to 125°, with an average of 110°. Two children could not cooperate with early rehabilitation treatment due to pain, and the knee flexion range of motion was not ideal (50°, 75°). All patients achieved acceptable lower limb function with MSTS scores ranged from 26 to 30, with an average of 28. All patients walked without crutches.
Conclusion: The treatment of malignant bone tumors around the knee joint with 3D printed osteotomy guide plate and personalized prosthesis can preserve the articular surface, obtain good limb function, reduce the risk of aseptic loosening of prosthesis, and achieve better mid-term effectiveness.

Entities:  

Keywords:  Tumor around knee joint; joint‐preserving; osteotomy guide plate; personalized prosthesis; three‐dimensional printing technique

Mesh:

Year:  2022        PMID: 35848175      PMCID: PMC9288916          DOI: 10.7507/1002-1892.202202080

Source DB:  PubMed          Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi        ISSN: 1002-1892


  18 in total

1.  Survival of total knee replacement with a megaprosthesis after bone tumor resection.

Authors:  David Biau; Florent Faure; Sandrine Katsahian; Cécile Jeanrot; Bernard Tomeno; Philippe Anract
Journal:  J Bone Joint Surg Am       Date:  2006-06       Impact factor: 5.284

2.  Computer-aided designed, three dimensional-printed hemipelvic prosthesis for peri-acetabular malignant bone tumour.

Authors:  Baichuan Wang; Yongqiang Hao; Feifei Pu; Wenbo Jiang; Zengwu Shao
Journal:  Int Orthop       Date:  2017-09-27       Impact factor: 3.075

3.  Reconstruction using an autograft containing tumour treated by liquid nitrogen.

Authors:  H Tsuchiya; S L Wan; K Sakayama; N Yamamoto; H Nishida; K Tomita
Journal:  J Bone Joint Surg Br       Date:  2005-02

4.  Intercalary femur allografts are an acceptable alternative after tumor resection.

Authors:  Luis Aponte-Tinao; Germán L Farfalli; Lucas E Ritacco; Miguel A Ayerza; D Luis Muscolo
Journal:  Clin Orthop Relat Res       Date:  2012-03       Impact factor: 4.176

5.  Epiphysis preserving resection of malignant proximal tibial tumours.

Authors:  Sándor Kiss; Tamás Terebessy; György Szöke; János Kiss; Imre Antal; Miklós Szendröi
Journal:  Int Orthop       Date:  2012-12-07       Impact factor: 3.075

6.  Survival of modern knee tumor megaprostheses: failures, functional results, and a comparative statistical analysis.

Authors:  Elisa Pala; Giulia Trovarelli; Teresa Calabrò; Andrea Angelini; Caterina N Abati; Pietro Ruggieri
Journal:  Clin Orthop Relat Res       Date:  2015-03       Impact factor: 4.176

7.  Three-dimensional-printed intercalary prosthesis for the reconstruction of large bone defect after joint-preserving tumor resection.

Authors:  Weijian Liu; Zengwu Shao; Saroj Rai; Binwu Hu; Qiang Wu; Hongzhi Hu; Shuo Zhang; Baichuan Wang
Journal:  J Surg Oncol       Date:  2020-01-04       Impact factor: 3.454

8.  Growth of epiphysis after epiphyseal-preservation surgery for childhood osteosarcoma around the knee joint.

Authors:  Akihiko Takeuchi; Norio Yamamoto; Katsuhiro Hayashi; Hidenori Matsubara; Hiroaki Kimura; Shinji Miwa; Takashi Higuchi; Kensaku Abe; Yuta Taniguchi; Hiroyuki Tsuchiya
Journal:  BMC Musculoskelet Disord       Date:  2018-06-06       Impact factor: 2.362

9.  Complex joint-preserving bone tumor resection and reconstruction using computer navigation and 3D-printed patient-specific guides: A technical note of three cases.

Authors:  Kwok Chuen Wong; Louis Kwan Yik Sze; Shekhar Madhukar Kumta
Journal:  J Orthop Translat       Date:  2021-06-24       Impact factor: 5.191

10.  Intercalary Reconstruction of the "Ultra-Critical Sized Bone Defect" by 3D-Printed Porous Prosthesis After Resection of Tibial Malignant Tumor.

Authors:  Dingyun Zhao; Fan Tang; Li Min; Minxun Lu; Jie Wang; Yuqi Zhang; Kun Zhao; Yong Zhou; Yi Luo; Chongqi Tu
Journal:  Cancer Manag Res       Date:  2020-04-08       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.